Search results for "breast neoplasm"

showing 10 items of 809 documents

Steroid Patterns of Benign Breast Disease

1990

We briefly review some biochemical aspects of benign breast disease (BBD), mainly focusing on free and conjugate estrogen content of breast cyst fluid (BCF), also in relation to cyst type. Evidence is reported that high K(+)-type I-cysts clearly associate with low Cl- levels and accumulate significantly higher quantities of dehydroepiandrosterone sulfate (DHAS) and estrone-3-sulfate (E1S). In spite of the limited number of cases, both increasing DHAS and E1S levels correlate with the increment of K+ to Na+ ratio. A positive correlation was also found between DHAS and E1S. Using electrochemical detection (ECD) on-line to high performance liquid chromatography (HPLC) in the reverse phase mode…

medicine.medical_specialtyEstronemedicine.drug_classmedicine.medical_treatmentBreast NeoplasmsEstroneGeneral Biochemistry Genetics and Molecular BiologySteroidchemistry.chemical_compoundDehydroepiandrosterone sulfateBreast cancerHistory and Philosophy of ScienceInternal medicinemedicineHumansCystFibrocystic Breast DiseaseChromatography High Pressure LiquidDehydroepiandrosterone SulfateGeneral NeuroscienceSulfataseEstrogensDehydroepiandrosteroneMiddle Agedmedicine.diseaseEndocrinologychemistryEstrogenFemaleBreast diseaseAdenofibromaAnnals of the New York Academy of Sciences
researchProduct

The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

2007

Background: Insulin receptor substrate 1 (IRS-1) is a signaling molecule that exerts a key role in mediating cross talk between estrogen receptor a (ERa) and insulin-like growth factor 1 (IGF-1) in breast cancer cells. Previously, we demonstrated that a fraction of IRS-1 binds ERa, translocates to the nucleus, and modulates ERa-dependent transcription at estrogen response elements (ERE). Here, we studied structure-function relationships of the ER-a:IRS-1 complex under IGF-1 and/or estradiol (E 2 ) stimulation. Materials and methods: ERa and IRS-1 deletion mutants were used to analyze structural and functional ERα/IRS-1 interactions. IRS-1 binding to ERE and IRS-1 role in ERa-dependent ERE t…

medicine.medical_specialtyInsulin Receptor Substrate ProteinsActive Transport Cell NucleusEstrogen receptorRepressorBreast NeoplasmsBiologyStructure-Activity Relationshipestrogen receptor alpha (ERa) Insulin receptor substrate 1 (IRS-1) breast cancerCell Line TumorInternal medicineCoactivatormedicineHumansInsulin-Like Growth Factor IReceptors InterferonEstradiolEstrogen Receptor alphaHematologyDNA-binding domainPhosphoproteinsPeptide FragmentsReceptor InsulinProtein Structure TertiaryCell biologyIRS1Repressor ProteinsPleckstrin homology domainEndocrinologyOncologyInsulin Receptor Substrate ProteinsFemaleChromatin immunoprecipitationProtein BindingAnnals of Oncology
researchProduct

Evaluation of the methodological quality of articles on autologous breast reconstruction

2018

Abstract Background Breast cancer remains the most common cancer among women worldwide. Autologous breast reconstruction may contribute toward restoring body image and improving quality of life after mastectomy. This systematic literature review describes differences in the quality and type of studies investigating autologous breast reconstruction techniques over time. Methods MEDLINE was searched for articles related to the surgical techniques, namely, TRAM, LADO, DIEP, and SGAP/IGAP, for the periods 1970 to 2007 and 2008 to 2010. The quality and type of studies were compared across the two time periods. Full-texts were evaluated according to prespecified quality criteria. Results The MEDL…

medicine.medical_specialtyMammaplastymedicine.medical_treatmentMEDLINEBreast Neoplasms030230 surgeryTransplantation Autologous03 medical and health sciences0302 clinical medicineBreast cancerQuality of lifemedicineHumansMethodological qualityMastectomybusiness.industrymedicine.diseaseChecklistSurgerySystematic review030220 oncology & carcinogenesisFemaleSurgeryPeriodicals as TopicbusinessBreast reconstructionMastectomyJournal of Plastic, Reconstructive & Aesthetic Surgery
researchProduct

Undetected Malignancies of the Breast: Dynamic Contrast-enhanced MR Imaging at 1.0 T

2002

To assess the prevalence and characteristics of malignant breast lesions not identified with magnetic resonance (MR) imaging.Breast tissue specimens were obtained in 464 of 967 patients who had undergone dynamic gadolinium-enhanced T1-weighted fast low-angle shot three-dimensional MR imaging of both breasts. A comparison of sensitivity, specificity, and predictive values of the prospectively recorded findings of mammography, ultrasonography (US), and MR imaging with the histopathologic results was performed with receiver operating characteristic (ROC) curve analysis. MR imaging examination findings that caused a false-negative diagnosis were reviewed to identify possible sources of error.Hi…

medicine.medical_specialtyMammary glandBreast NeoplasmsGadoliniumSensitivity and SpecificityPredictive Value of TestsmedicineHumansMammographyRadiology Nuclear Medicine and imagingmedicine.diagnostic_testReceiver operating characteristicbusiness.industryCurve analysisMagnetic resonance imagingImage EnhancementMagnetic Resonance ImagingMr imagingDynamic contrastmedicine.anatomical_structureROC CurveFemaleHistopathologyUltrasonography MammaryRadiologyArtifactsNuclear medicinebusinessRadiology
researchProduct

Lack of binding of gestodene to estrogen receptor in human breast cancer tissue

1990

Competition studies with progesterone and estradiol receptors of human myometrial tissue as well as of mammary cancer tissue showed that gestodene bound with high affinity to the progesterone receptor, as did other synthetic and natural progestogens. However, gestodene did not bind to the estradiol receptor. The relative binding affinities of all tested synthetic and natural ligands showed no organ-specific differences and no differences between neoplastically transformed and normal tissues.

medicine.medical_specialtyNorpregnenesNormal tissueEstrogen receptorBreast NeoplasmsIn Vitro TechniquesBiologyGestodeneBinding CompetitivePromegestoneInternal medicineProgesterone receptormedicineHumansReceptorBinding affinitiesProgesterone CongenersCancermedicine.diseaseEndocrinologyReceptors EstrogenOncologyMyometriumFemaleReceptors ProgesteroneHuman breasthormones hormone substitutes and hormone antagonistsmedicine.drugEuropean Journal of Cancer and Clinical Oncology
researchProduct

Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases

1995

The authors describe one case of a rare primitive non-Hodgkin lymphoma of the uterus, and two cases of primary non-Hodgkin lymphoma of the breast. Histologically, the uterine lymphoma, although clinically confined to the uterus, was a diffuse large cell lymphoma, group G according to the Working formulation for Clinical Usage. The two cases of breast lymphoma were a centrocytic-centroblastic and a lymphoplasmocytoid non-Hodgkin lymphoma, respectively. All cases were initally treated with radical surgery plus radiotherapy, but the first patient showed an early recurrence at distant sites, which required systemic cytotoxic chemotherapy. The patient with uterine non-Hodgkin lymphoma received a…

medicine.medical_specialtyPathologyWorking Formulationmedicine.medical_treatmentMammary glandUterusBreast NeoplasmsCHOPimmune system diseaseshemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineRadical surgeryChemotherapybusiness.industryLymphoma Non-HodgkinGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyLymphomaRadiation therapymedicine.anatomical_structureOncologyUterine NeoplasmsFemaleSurgeryLymphoma Large B-Cell DiffuseRadiologybusinessEuropean Journal of Surgical Oncology (EJSO)
researchProduct

Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells.

2001

Parathyroid hormone-related protein (PTHrP) is critical for normal mammary development and is overexpressed by breast cancers. PTHrP is a peptide hormone that undergoes extensive post-translational processing, and PTHrP(38–94)-amide is one of the mature secretory forms of the peptide. In this study, we explored the effect of PTHrP(38–94)-amide in a panel of six breast cancer cell lines “in vitro” and in MDA-MB231 cells “in vivo” specifically examining cell viability, proliferation, invasiveness, and growth in nude mice. PTHrP(38–94)-amide markedly inhibited proliferation and also caused striking toxicity and accelerated cell death in breast cancer cells. In addition, direct injection of PTH…

medicine.medical_specialtyProgrammed cell deathEndocrinology Diabetes and MetabolismMammary glandMice NudeAntineoplastic AgentsBreast NeoplasmsCell CountBiologymedicine.disease_causeMiceInternal medicinemedicineTumor Cells CulturedAnimalsHumansOrthopedics and Sports MedicineNeoplasm Invasivenessskin and connective tissue diseasesParathyroid hormone-related proteinCell growthParathyroid Hormone-Related ProteinCancerProteinsNeoplasms Experimentalmedicine.diseasePeptide FragmentsDisease Models AnimalEndocrinologymedicine.anatomical_structureCell cultureCancer cellCancer researchFemaleCarcinogenesishormones hormone substitutes and hormone antagonistsCell DivisionJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
researchProduct

Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.

2017

Abstract Context Cancer patients frequently suffer from fatigue. Recently, the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life group developed a new 12-item fatigue assessment instrument. Objectives The aim of this study was to psychometrically test this questionnaire in comparison with the three-item fatigue scale of the EORTC QLQ-C30. Methods A sample of 354 patients who were being treated for breast cancer or gynecologic cancer were examined using the new fatigue questionnaire EORTC QLQ-FA12 and the EORTC QLQ-C30 during their hospital stay (t1) and three months after hospital discharge (t2). Confirmatory factorial analyses, item analyses, test-retest re…

medicine.medical_specialtyPsychometricsPsychometricsGenital Neoplasms FemaleContext (language use)Breast NeoplasmsSeverity of Illness Index03 medical and health sciences0302 clinical medicineBreast cancerCronbach's alphaQuality of lifeSurveys and Questionnairesotorhinolaryngologic diseasesmedicineHospital dischargeHumans030212 general & internal medicineGeneral NursingFatigueAgedbusiness.industryCancerReproducibility of Resultssocial sciencesMiddle Agedmedicine.diseasehumanitiesAnesthesiology and Pain Medicine030220 oncology & carcinogenesisPhysical therapyFemaleNeurology (clinical)Factorial analysisbusinessFactor Analysis StatisticalJournal of pain and symptom management
researchProduct

Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer.

2021

Abstract Background Sentinel lymph node biopsy is the gold standard surgical technique for axillary staging in patients with clinically node-negative. However, it is still uncertain what is the optimal number of sentinel lymph nodes (SLNs) to be removed to reduce the false-negative rate. The aim of this study was to investigate whether patients with a single negative SLN have a worse prognosis than those with two or more negative SLNs. Methods A retrospective review was conducted on a large series of SLN-negative breast cancer patients. Survival outcomes and regional recurrence rate were evaluated according to the number of removed SLNs. Secondly, the contribution of different adjuvant ther…

medicine.medical_specialtyRD1-811SurvivalSentinel lymph nodeUrologyBreast NeoplasmsBreast cancerBreast cancerBiopsyMedicineHumansSurvival analysisRC254-282Retrospective Studiesmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyOptimal numberResearchNeoplasms. Tumors. Oncology. Including cancer and carcinogensRetrospective cohort studySentinel nodemedicine.diseasePrognosisAxillamedicine.anatomical_structureOncologyAxillary stagingAxillaLymph Node ExcisionSurgeryFemaleLymphLymph NodesNeoplasm Recurrence LocalSentinel Lymph NodebusinessFalse-negative rateWorld journal of surgical oncology
researchProduct

Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data

2020

Objectives To estimate total direct health care costs associated to diagnosis and treatment of women with breast cancer in Italy, and to investigate their distribution by service type according to the disease pathway and patient characteristics. Methods Data on patients provided by population-based Cancer Registries are linked at individual level with data on health-care services and corresponding claims from administrative databases. A combination of cross-sectional approach and a threephase of care decomposition model with initial, continuing and final phases-of-care defined according to time occurred since diagnosis and disease outcome is adopted. Direct estimation of cancer-related cost…

medicine.medical_specialtyReal world dataTotal costEconomics Econometrics and Finance (miscellaneous)PopulationHealth care utilizationAdministrative dataBreast NeoplasmsSettore MED/42 - Igiene Generale E Applicata03 medical and health sciencesInsurance Claim Review0302 clinical medicineBreast cancerBreast cancerEnvironmental healthHealth careCost analysiCost analysisMedicineHumans030212 general & internal medicineRegistrieseducationRetrospective Studieseducation.field_of_studyHealth economicsbusiness.industry030503 health policy & servicesHealth PolicyPublic healthmedicine.diseaseHospitalizationCross-Sectional StudiesItalyCost driverCohortFemaleHealth Expenditures0305 other medical sciencebusinessDelivery of Health Care
researchProduct